title: Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response.
abstract: Dendritic cells (DC), which are essential for inducing and regulating immune defenses and responses, represent the critical target for vaccines against pathogens such as foot-and-mouth disease virus (FMDV). Although it is clear that FMDV enters epithelial cells via integrins, little is known about FMDV interaction with DC. Accordingly, DC internalization of FMDV antigen was analyzed by comparing vaccine virus dominated by heparan sulfate (HS)-binding variants with FMDV lacking HS-binding capacity. The internalization was most efficient with the HS-binding virus, employing diverse endocytic pathways. Moreover, internalization relied primarily on HS binding. Uptake of non-HS-binding virus by DC was considerably less efficient, so much so that it was often difficult to detect virus interacting with the DC. The HS-binding FMDV replicated in DC, albeit transiently, which was demonstrable by its sensitivity to cycloheximide treatment and the short duration of infectious virus production. There was no evidence that the non-HS-binding virus replicated in the DC. These observations on virus replication may be explained by the activities of viral RNA in the DC. When DC were transfected with infectious RNA, only 1% of the translated viral proteins were detected. Nevertheless, the transfected cells, and DC which had internalized live virus, did present antigen to lymphocytes, inducing an FMDV-specific immunoglobulin G response. These results demonstrate that DC internalization of FMDV is most efficient for vaccine virus with HS-binding capacity, but HS binding is not an exclusive requirement. Both non-HS-binding virus and infectious RNA interacting with DC induce specific immune responses, albeit less efficiently than HS-binding virus.
authors.affiliation: Institute of Virology and Immunoprophylaxis, CH-3147 Mittelhäusern, Switzerland. Lisa.Harwood@ivi.admin.ch
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Harwood
authors.forename: Heidi
authors.initials: H
authors.lastname: Gerber
authors.forename: Francisco
authors.initials: F
authors.lastname: Sobrino
authors.forename: Artur
authors.initials: A
authors.lastname: Summerfield
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: McCullough
mesh_terms: D045744:Cell Line, Tumor; D003513:Cycloheximide / Q000494:pharmacology; D003713:Dendritic Cells / Q000276:immunology* / Q000821:virology*; D005434:Flow Cytometry; D029544:Foot-and-Mouth Disease Virus / Q000378:metabolism / Q000502:physiology*; D006497:Heparan Sulfate / Q000378:metabolism*; D006801:Humans; D008856:Microscopy, Fluorescence; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D053586:Virus Internalization; D014779:Virus Replication / Q000187:drug effects
chemical_list: D003513:Cycloheximide; D006497:Heparan Sulfate; D011500:Protein Synthesis Inhibitors